Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
32.6M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
22.5M
-
Shares change
-
-452K
-
Total reported value, excl. options
-
$95.3M
-
Value change
-
-$45.5M
-
Put/Call ratio
-
2.36
-
Number of buys
-
51
-
Number of sells
-
-32
-
Price
-
$4.23
Significant Holders of Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) as of Q4 2024
110 filings reported holding ANRO - Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
Alto Neuroscience, Inc. - Common Stock, $0.0001 par value per share (ANRO) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.5M shares
of 32.6M outstanding shares and own 69.21% of the company stock.
Largest 10 shareholders include Alpha Wave Global, LP (3.71M shares), Point72 Asset Management, L.P. (1.69M shares), BlackRock, Inc. (1.48M shares), FMR LLC (1.27M shares), VANGUARD GROUP INC (1.23M shares), FRANKLIN RESOURCES INC (1.16M shares), CITADEL ADVISORS LLC (976K shares), Vestal Point Capital, LP (915K shares), PRICE T ROWE ASSOCIATES INC /MD/ (845K shares), and MARSHALL WACE, LLP (837K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.